Helio Genomics Appoints Experienced Healthtech Executive John Doyle to BOD
Board appointment strengthens governance, innovation strategy, and long–term value creation in AI–driven early disease detection. Helio Genomics, Inc., an AI-powered TechBio company focused on early...
